Cargando…
Antiphospholipid Antibody Induced by Nivolumab
Nivolumab is a monoclonal antibody against the programmed death protein 1 and is used for patients with advanced melanoma. It is associated with potentially immune-related adverse events, including disorders of the skin, GI tract, and the thyroid; these disorders were successfully treated with predn...
Autores principales: | Aburahma, Ahmed, Aljariri Alhesan, Nour, Elounais, Farah, Abu Sitta, Emad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821982/ https://www.ncbi.nlm.nih.gov/pubmed/29581905 http://dx.doi.org/10.1155/2018/3106852 |
Ejemplares similares
-
Seizure Associated Takotsubo Syndrome: A Rare Combination
por: Kyi, Htay Htay, et al.
Publicado: (2017) -
SUN-057 Familial Partial Lipodystrophy Presenting As Recurrent Acute Pancreatitis- Challenges In Management
por: Aljariri Alhesan, Nour, et al.
Publicado: (2019) -
Mycoplasma pneumoniae‐associated Fuchs syndrome
por: Kheiri, Babikir, et al.
Publicado: (2017) -
Chorea Associated with High Titers of Antiphospholipid Antibodies in the Absence of Antiphospholipid Antibody Syndrome
por: Safarpour, Damoun, et al.
Publicado: (2015) -
Antiphospholipid Antibody Syndrome Presenting with Hemichorea
por: Ayalew, Yezenash, et al.
Publicado: (2012)